Pioglitazone, etoricoxib, interferon-α, and metronomic capecitabine for metastatic renal cell carcinoma: final results of a prospective phase II trial
Article
Walter, B., Schrettenbrunner, I., Vogelhuber, M., Grassinger, J., Bross, K., Wilke, J., Suedhoff, T., Berand, A., Wieland, W. F., Rogenhofer, S., Andreesen, R. and Reichle, A. (2012) Pioglitazone, etoricoxib, interferon-α, and metronomic capecitabine for metastatic renal cell carcinoma: final results of a prospective phase II trial. Medical Oncology 29 (2), pp. 799-805.Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | Medical Oncology | ||||
| Publisher | HUMANA PRESS INC | ||||
| Place of Publication | TOTOWA | ||||
| Volume | 29 | ||||
| Number of Issue or Book Chapter | 2 | ||||
| Page Range | pp. 799-805 | ||||
| Date | 2012 | ||||
| Date of publication | 19 Dec 2024 09:40 | ||||
| Institutions | Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie) Medicine > Lehrstuhl für Urologie | ||||
| Identification Number |
| ||||
| Keywords | C-REACTIVE PROTEIN; INFLAMMATORY RESPONSE; PPAR-GAMMA; CANCER; SURVIVAL; THERAPY; INTERLEUKIN-6; CHEMOTHERAPY; COMBINATION; TARGET; Metastatic renal cell carcinoma; Anti-inflammatory agents; Metronomic chemotherapy; C-reactive protein; Tumor microenvironment | ||||
| Dewey Decimal Classification | 600 Technology > 610 Medical sciences Medicine | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 63730 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric